Private markets and public investors continue to collide in new and interesting ways. Interval funds allow individual investors to commit their capital to strategies that invest directly in private ...

ARS Pharmaceuticals, Inc. has announced the addition of neffy® (epinephrine nasal spray) to the formularies of Cigna Healthcare, Navitus Health Systems, and OptumRx, expanding access to approximately ...

EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in ...

CELEBRATION, Fla., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with ...

Last fall, Jody Dushay, MD, an endocrinologist at Beth Israel Deaconess Medical Center in Boston, got a message from her patient with type 2 diabetes. His pharmacy had one semaglutide (Ozempic) pen ...

What is the ReMarkable 2? ReMarkable 2 is hailed as “the world’s thinnest tablet,” according to the ReMarkable website. Specifically, it’s a “paper tablet” on which you can digitally take notes, ...

From March 16th, LastPass users of its free package will only be able to use the password manager on one “device type” at a time, down from two. LastPass is claiming that the decision was necessary as ...